investors.hartehanks.com
Harte Hanks Reports Second Quarter Results (NYSE:HHS)
http://investors.hartehanks.com/releasedetail.cfm?ReleaseID=924703
Jul 30, 2015. File is in Briefcase. Harte Hanks Reports Second Quarter Results. NEW YORK, NY. NYSE: HHS), a leader in developing customer relationships, experiences and defining interaction-led marketing, today announced financial results for its second quarter ended. June 30, 2015. Second quarter 2015 adjusted diluted earnings per share were. Loss on the sale of its B2B research businesses, compared to. For the same quarter in 2014. Second quarter 2015 revenues were. During the same quarter last year.
resources.hartehanks.com
Pharma
http://resources.hartehanks.com/h/c/219222-pharma
Harte Hanks Resource Center. How Pharmaceutical CRMs Can Lead to Healthier Relationships. Boosting physician and patient engagement Customer Relationship Management (CRM) software offers a great deal of potential for the pharmaceutical industry. However, this is a complex sector,. To manage competitive AEP pressures? Error - something went wrong! Error - something went wrong! How the pharma industry can benefit from custom-built CRM: https:/ t.co/06JSnCvs2A. Digital and Social Media. Follow us for updates.
SOCIAL ENGAGEMENT